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The Colony-Stimulating Factor 1 Receptor Is Expressed on
Dendritic Cells during Differentiation and Regulates Their
Expansion1
Kelli P. A. MacDonald,2* Vanessa Rowe,* Helen M. Bofinger,* Ranjeny Thomas,†
Tedjo Sasmono,‡ David A. Hume,‡ and Geoffrey R. Hill*
The lineage of dendritic cells (DC), and in particular their relationship to monocytes and macrophages, remains obscure. Fur-
thermore, the requirement for the macrophage growth factor CSF-1 during DC homeostasis is unclear. Using a transgenic mouse
in which the promoter for the CSF-1R (c-fms) directs the expression of enhanced GFP in cells of the myeloid lineage, we deter-
mined that although the c-fms promoter is inactive in DC precursors, it is up-regulated in all DC subsets during differentiation.
Furthermore, plasmacytoid DC and all CD11chigh DC subsets are reduced by 50–70% in CSF-1-deficient osteopetrotic mice,
confirming that CSF-1 signaling is required for the optimal differentiation of DC in vivo. These data provide additional evidence
that the majority of tissue DC is of myeloid origin during steady state and supports a close relationship between DC and
macrophage biology in vivo. The Journal of Immunology, 2005, 175: 1399–1405.
D endritic cells (DC)3 represent a heterogeneous populationof APCs, which include CD11cCD4, CD11cCD8,CD11cCD4CD8, and CD11cdimB220 subsets in the
mouse. The relationship between the various DC subsets and cell
lineage remains highly controversial. Although it is clear that they can
be differentiated from both monocytes and granulocyte myeloid pre-
cursors (1), well-constructed studies also indicate that some DC may
derive from common lymphoid precursors (2, 3). The expression of
the c-fms gene (which encodes for CSF-1R) is restricted to cells of the
myeloid lineage and is a marker of macrophage differentiation (4). We
have recently described the MacGreen transgenic mouse in which the
promoter for the CSF-1R (c-fms) directs the expression of enhanced green
fluorescent protein (EGFP) by all cells of the monocyte/macrophage
lineage (5). In the current study, we used MacGreen and CSF-1-de-
ficient osteopetrotic (op/op) mice to determine whether distinct sub-
sets of DC could be distinguished by the differential expression of the
CSF-1R or their developmental requirement for CSF-1 signaling.
Materials and Methods
Mice
MacGreen mice were produced on a B6  CBAF1 background as de-
scribed previously (5). Homozygous op/op and heterozygous op/wt mice
were supplied by the Herston Medical Research Centre (Brisbane, Austra-
lia). C57BL/6 mice were supplied by the Animal Resource Centre (West-
ern Australia, Australia). All mice used were 5–12 wk of age.
Cytokine treatment
Recombinant progenipoietin-1 (ProGP-1) (Pfizer) was diluted in 1 g/ml
murine serum albumin in PBS before injection. Mice were injected s.c.
with diluent or 20 g/animal/day ProGP-1 once daily from days7 to1.
Complete blood counts were performed on EDTA peripheral blood (PB)
samples using a Sysmex SE-9000 (Sysmex) automated analyser.
Monoclonal Abs
The following mAbs were purchased from BD Pharmingen: FITC-conju-
gated CD11c (HL3) and IgG2a isotype control; PE-conjugated CD4
(GK1.5), CD8a (53-6.7), CD11b (M1/70), CD11c (HL3), CD40 (3/23),
CD45R/B220 (RA3-6B2), CD80 (16-10A1), CD86 (GL1), I-A/I-E (2G9),
and IgG2b isotype control; and PE-Cy5-conjugated CD8 CD4 and IgG2b
isotype control. PE-conjugated CD115 was purchased from Serotec. Puri-
fied mAb against CD3 (KT3), CD19 (HB305), Gr1 (RB6-8C5), Thy1.2
(HO-13-4), Ter119, FcR II/III (2.4G2), and biotinylated F4/80 were pro-
duced in house.
Cell preparation
DC purification was undertaken as described previously (6). Briefly, low-
density cells were enriched from digested lymphoid tissues, bone marrow,
or lysis buffer-treated heparinized blood by Nycodenz density gradient cen-
trifugation. In some experiments, non-DC lineage cells were depleted by
coating with rat IgG Abs to B cells (CD19), T cells (CD3, Thy1), granu-
locytes (Gr-1), and erythroid cells (Ter-119). The coated cells were then
removed by magnetic beads coupled to anti-rat IgG (Dynal ASA, Oslo,
Norway). For mixed lymphocyte cultures (MLC), splenic T cells were
purified by depleting B cells (B220 and CD19), monocytes (CD11b), gran-
ulocytes (Gr-1), and erythroid cells (Ter-119) using magnetic bead deple-
tion. For culture experiments, highly purified DC populations (98%)
were obtained by FACS (MoFlo; DakoCytomation). Peritoneal cells were
lavaged from the peritoneal cavity with HBSS containing EDTA
(Sigma-Aldrich).
Real-time RT-PCR for CSF-1R
For real-time RT-PCR analysis, equivalent numbers of sort-purified cells
were resuspended in TRIzol (Invitrogen Life Technologies), snap frozen on
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dry ice, and RNA extracted, according to the manufacturers protocol.
cDNA was immediately reverse transcribed using avion myeloblastosis
reverse transcriptase (Promega), according the manufacturers protocol, and
cDNA stored at 20°C. Real-time PCR was undertaken using Platinum
SYBR Green qPCR SuperMix UDG (Invitrogen Life Technologies) con-
ducted on a Rotor-Gene3000 (Corbett Research) and data analyzed using
Rotor-Gene v5.0 (Corbett Research). Primers used for CSF-1R reactions
were 5-CCACCATCCACTTGTATGTCAAAGAT-3 (forward) and 5-
CTCAACCACTGTCACCTCCTGT-3 (reverse). Primers used for 2-mi-
croglobulin reactions were 5-TTTCTGGTGCTTGTCTCACTGACCG-3
(forward) and 5-GCAGTTCAGTATGTTCGGCTTCCCA-3 (reverse).
The thermal cycler conditions were as follows: 1  2 min 50°C, 1  10
min 95°C, 40–50 cycles denaturation (15 s, 95°C), and combined anneal-
ing/extension (1 min, 60°C). CSF-1R cDNA copy numbers were then nor-
malized for variations in the efficiency of RNA extraction and cDNA tran-
scription against the 2-microglobulin housekeeping gene.
Cell culture
Sort-purified CD11cc-fms/EGFPneg PB cells were cultured at 106/ml for
7–9 days in 10% FCS/IMDM (JRH Biosciences) supplemented with GM-
CSF, IL-3, and IL-4 (all at 100 ng/ml). Sort-purified CD11chigh and
CD11cdimB220 DC were cultured for 18 h at 106/ml in 10% FCS/IMDM
supplemented with GM-CSF, IL-3 (each at 100 ng/ml), LPS (1 g/ml), and
phosphorothioated oligo CpG (1668; 0.5 M) (7). For MLC, 106 magnetic
bead-purified C57BL/6 T cells were cultured for 5 days with varying
numbers of sort-purified CD11chigh DC. [3H]Thymidine (1 Ci/well)
was added on day 4, and proliferation was determined 18 h later using
a Betaplate Reader (Wallac).
Results
CD11chigh and CD11cdimB220 DC express c-fms
We first compared c-fms expression by peritoneal macrophages
and splenic DC subsets using three-color flow cytometry. For these
experiments, DC were highly enriched from MacGreen and
C57BL/6 spleens by density gradient centrifugation and magnetic
bead depletion of lineage-positive cells. CD11chigh (myeloid) and
CD11cdimB220 (plasmacytoid) cells were gated (Fig. 1a) and
examined for c-fms transgene reporter expression. Peritoneal F4/
80 macrophages and both DC subsets in MacGreen mice ex-
pressed c-fms/EGFP; however, the level of expression in the F4/
80 macrophages and the CD11chigh DC was higher than that of
the CD11cdimB220 DC subset (Fig. 1b). In contrast to F4/80
macrophages, which expressed high levels of surface CSF-1R us-
ing a CD115 mAb, only low-level surface CSF1R was detected on
either DC subset, and again, the CD11chigh DC staining was brighter
than that of the CD11cdimB220 DC subset (Fig. 1b). The differential
expression of CSF-1R by peritoneal F4/80macrophages and the two
DC subsets was confirmed by real-time PCR analysis. The expression
FIGURE 1. Splenic CD11chigh and
CD11cdim B220 DC express c-fms.
Splenic DC were enriched from
MacGreen or C57BL/6 mice by gradi-
ent centrifugation and lineage depletion
and CD11chigh and CD11cdimB220
populations gated (a) and examined for
c-fms/EGFP or CSF-1R (CD115) ex-
pression (thick line) (b). Negative con-
trols (fine line) are from c-fms/EGFP-
negative littermates or isotype control
mAb, respectively. Peritoneal F4/80
macrophages served as a positive con-
trol for c-fms/EGFP and CSF-1R ex-
pression. Normalized CSF-1R mRNA
levels were determined by SYBR green
real-time PCR analysis of total RNA
isolated from sort-purified cell popula-
tions as described in Materials and
Methods. Data are presented as mean
values with SDs from triplicate samples
and are representative of one of three
independent experiments with similar
results (c). The capacity of sort-purified
wild-type or MacGreen CD11chigh DC
to stimulate allogeneic (H-2b) T cell
proliferation was determined in an
MLC using [3H]thymidine incorpora-
tion as a readout (d).
1400 c-fms EXPRESSION ON DCs
 by guest on January 22, 2014
http://w
w
w
.jimmunol.org/
D
ow
nloaded from
 
of CSF-1R mRNA in F4/80 macrophages was 5-fold that of
CD11chigh DC, which was 2-fold higher than the CD11cdimB220
DC. (Fig. 1c). As expected, CSF-1R mRNA was not detected in
CD4 T cells. Finally, the presence of the EGFP reporter gene in the
MacGreen mice did not alter the stimulatory capacity of CD11c DC
(Fig. 1d).
Examination of EGFP expression within the skin, thymus, and
lymph nodes from MacGreen mice revealed EGFP bright cells
included cells with DC morphology. In this regard, within epider-
mal sheets, Langerhans cells were clearly demarcated by EGFP
expression, whereas cells with pronounced interdigitating pro-
cesses were evident within the thymic cortex. In addition to the
strong expression of EGFP in the macrophages of the subcapsular
sinus, note the extensive dendritic network of EGFP-positive cells
through the remainder of the lymph node (Fig. 2).
Because MacGreen mice permitted enhanced detection of c-fms
promoter activity, we used these mice to extend our analysis of
CD11c DC CSF-1R expression within various lymphoid organs.
For these experiments, DC were enriched from lymphoid tissues
by density gradient centrifugation. Greater than 90% of CD11c
cells within DC preparations from bone marrow, thymus, spleen,
and lymph nodes expressed c-fms/EGFP. In contrast, within the PB
DC preparations, 20–30% of the CD11c cells were EGFP neg-
ative (Fig. 3), corresponding to 6% of blood mononuclear cells.
PB contains a CD11cc-fms/GFPneg DC precursor population
Because a CD11cMHC-IIneg DC precursor population of similar
frequency to that of the CD11cc-fms/GFPneg PB population was
recently identified in murine PB (8), we investigated whether the
CD11cc-fms/GFPneg PB population related to this DC precursor.
To limit the number of animals required, we treated the MacGreen
mice with ProGP-1, a chimeric protein with receptor agonist ac-
tivity for both fetal liver tyrosine kinase-3 (Flt3) and G-CSF re-
ceptor that is known to expand both CD11chigh and
CD11cdimB220 DC in blood and lymphoid organs (9, 10).
ProGP-1 pretreatment of the MacGreen mice resulted in a 100-fold
increase in the blood white cell count and a 40-fold expansion of
blood CD11c DC, and this expansion was associated with both
the CD11cc-fms/GFPpos and CD11cc-fms/GFPneg populations
(Fig. 4a). Phenotypic analysis of the CD11cc-fms/GFPneg popu-
lation from ProGP-1-treated animals revealed the cells to be MHC
class IIneg, CD8neg, CD4neg, F4/80neg, CD11b, CD62Ldim, and
B220 (Fig. 4b). Notably, this phenotype is identical to that of the
DC precursor described by del Hoyo (8).
Because the PB DC precursors have been shown to exhibit the
capacity to reconstitute all splenic DC populations, we examined
whether the differentiation of CD11cc-fms/GFPneg population
would induce the expression of c-fms/EGFP. Following 7–9 days
in culture in the presence of GM-CSF, IL-4, and IL-3, sort-purified
CD11cGFPneg DC precursors differentiated into large DC-like
cells (based on forward and side scatter characteristics) and ex-
pressed c-fms/EGFP (Fig. 5).
All DC subsets are reduced in CSF-1-deficient op/op mice
Because CSF-1R was found to be associated with DC maturation,
we asked whether CSF-1 signaling was required for the generation
FIGURE 2. Tissue distribution of EGFP expression in MacGreen mice.
Immunofluorescence from EGFP within epidermis, thymus, and lymph
node (400). Note the positive cells with Langerhans morphology within
epidermal sheet and the extensive dendritic network of interdigitating GFP-
positive cells through the thymic cortex and lymph node.
FIGURE 3. Expression of c-fms by
DC subsets. DC from the various tis-
sues of MacGreen mice were enriched
by gradient centrifugation as de-
scribed in Materials and Methods and
examined for c-fms/EGFP expression
using two-color flow cytometry.
Quadrants were assigned using iso-
type control mAb (PE channel) and
DC preparations from c-fms/EGFP-
negative littermates (FITC channel).
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and/or differentiation of DC. For these studies, we used op/op
mice, which have a null mutation in the CSF-1 gene that results in
congenital osteopetrosis (11) due to a deficiency of osteoclasts and
macrophages (12). As expected, F4/80-positive peritoneal macro-
phages were largely absent in op/op mice (Table I). Examination
of DC within the op/op spleen revealed a 43 and 70% reduction in
the CD11chigh DC and CD11cdimB220 compartments, respec-
tively, compared with the normal heterozygous op/wt littermates.
In contrast, the relative frequency of the CD4, CD8, or
CD4CD8 subsets of the CD11chigh population was unchanged.
DC cell function and maturation is not altered in op/op mice
Functional testing of sort-purified CD11chigh DC in MLC revealed
that op/op DC were as potent at stimulating allogeneic T cell (C57/
BL6) proliferation as normal heterozygote op/wt DC (Fig. 6a).
Furthermore, following 18 h of culture in the presence of GM-
CSF, IL-3, LPS, and CpG, op/op and op/wt CD11chigh DC class II
and costimulatory molecule expression was equivalent (Fig. 6b).
Interestingly, following culture, the op/op CD11cdimB220 DC
exhibited enhanced expression of CD40 and CD86 as compared
with the op/wt CD11cdimB220 DC.
Discussion
DC represent a heterogeneous population whose lineage relation-
ship with other hemopoietic cell populations has long been ques-
tioned. Although DC were initially thought to be of myeloid ori-
gin, several recent studies using DC reconstitution experiments
have established that both common myeloid and lymphoid precur-
sors exhibit the capacity to differentiate into DC in vivo. However,
the relative contribution of either of these precursor populations
during normal DC development is not known. DC can be subdi-
vided into multiple subsets based on phenotype and tissue distri-
bution. Thus, within mouse spleen four unique CD11c DC sub-
sets (CD8, CD4, CD8CD4, and B220) can be identified.
Furthermore, DC populations include Langerhans cells and dermal
DC within the skin and CD8int DC within lymph nodes. Although
the various DC subpopulations appear to be developmentally and
functionally distinct, it is not clear whether this divergence can be
attributed to distinct lineages, different stages of development/ac-
tivation, or the influence of unique tissue specific niches.
CSF-1 drives the expansion and differentiation of macrophages,
which are well established to be of myeloid lineage. MacGreen
mice express EGFP driven by the c-fms promoter, thus permitting
identification of myeloid-derived cells. In this study, we demon-
strate that the MacGreen mouse represents a highly sensitive
means of amplifying CD115. This allowed assessment of the po-
tential for expression of the CSF-1R and confirmed that the ma-
jority of all tissue DC subsets expressed c-fms/EGFP. Conversely,
up to 30% of CD11c DC within the PB lacked c-fms/EGFP ex-
pression. The c-fms/EGFPnegCD11c PB population exhibited a
phenotype (class IIneg, CD11b, B220, and CD62L) identical
to that of a previously described blood DC precursor (8) and could
be induced to express c-fms/EGFP upon differentiation in vitro.
Although the data suggest that these c-fms/EGFPnegCD11c cells
are DC precursors, we cannot exclude the possibility that these are
CD11c cells of a separate lineage (e.g., lymphoid) or stage of
trafficking. However, these putative DC precursors resemble com-
mon myeloid progenitors purified from bone marrow in which
control elements of the c-fms locus are assembled into active chro-
matin, and c-fms mRNA expression is very low (13). The expres-
sion of c-fms is induced rapidly during macrophage lineage com-
mitment. In contrast to the intense c-fms/EGFP transgene
expression seen in mature DC populations, surface c-fms (CD115)
was expressed on DC at low levels only (3-log less than on F4/
FIGURE 4. PB contains a
CD11cc-fms/EGFPneg DC precursor
population. MacGreen mice were
treated with control diluent or
ProGP-1, and white counts were de-
termined as described in Materials
and Methods. c-fms/EGFP expression
was then determined in CD11c pop-
ulations using two-color flow cytom-
etry (a). Phenotypic analysis of the
CD11cc-fms/EGFPneg population
(R2 in a above) by three-color flow
cytometry using a panel of Ag-spe-
cific mAb (thick line). Isotype control
mAbs are shown as a fine line (b).
FIGURE 5. CD11cc-fms/EGFPneg DC precursor up-regulates c-fms
upon differentiation. Analysis of forward and side scatter characteristics
and c-fms/EGFP expression by the CD11cc-fms/EGFPneg population be-
fore (day 0, thin line) and after culture in vitro (day 7, shaded peak). Thick
line depicts level of c-fms/EGFP expression by freshly purified PB
CD11cc-fms/EGFPpos DC.
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80-positive macrophages), suggesting that the majority of c-fms
expression in DC is not surface bound. This finding does not imply
that the CSF-1R is inactive. For example, Langerhans cells have
been shown to express functional CSF-1R and respond to CSF-1
(14). c-fms mRNA is barely detectable in bone marrow myeloid
progenitors, yet the cells are clearly CSF-1 responsive (13). Tissue
FIGURE 6. T cell stimulatory capacity
of freshly purified op/op and op/wt
CD11chigh DC. Freshly purified CD11chigh
DC from op/wt and op/op (H-2b/k) spleens
were cultured in the presence of allogeneic
(H-2b) T cells and proliferation deter-
mined by [3H]thymidine incorporation (a).
Costimulatory molecule expression by in
vitro-matured op/wt and op/op DC sub-
sets. Sort-purified DC subsets from op/wt
and op/op spleens were cultured in the
presence of GM-CSF, IL-3, LPS, and
phosphorothioated oligo CpG. Cells were
harvested after 18 h and stained with PE-
conjugated mAb as indicated (b). Data are
from one experiment and represents one of
three sets of cultures of DC subsets de-
rived from individual op/wt and op/op
spleens.
Table 1. Frequency and subset composition of splenic DC
Peritoneal
Macrophages CD11chigh CD11cdimB220
CD11chigh Subsets (% of CD11chigh)
CD4 CD8 CD4CD8
op/wt 1.1 0.2 4.7  0.5 3.3  0.3 55.7  2.8 18.7  1.9 19.2  3.4
op/op 0.04 0.02* 2.7 0.3† 1.0  0.1† 56.3  3.7 21.6  2.3 17.6  2.1
Peritoneal macrophages (106/lavage) and DC (106/spleen) from individual osteopetrotic CSF-1-deficient op/op (n  5)
or normal heterozygote littermate op/wt (n  6) mice were characterized as described in Materials and Methods. Results
expressed as mean  SE. , p 	 0.01; †, p 	 0.05.
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macrophages express surface CSF-1R at much higher levels than
proliferating progenitors, and in these cells, the receptor mediates
endocytic clearance of the growth factor (15). The level of c-fms
mRNA is also down-modulated posttranscriptionally by GM-CSF,
which promotes DC differentiation (16, 17), and surface CSF-1R is
down-modulated acutely by TLR agonists (18). In contrast, EGFP
remains intracellular and therefore is not subject to variables that
influence both initial expression at the surface and subsequent deg-
radation. Therefore, the expression of the CSF-1R reporter gene is
not expected to be perfectly correlated with the presence of the
receptor on the cell surface. Taken together, these data suggest that
expression of c-fms promoter activity is a marker of maturation
within all DC subsets, and its absence identifies immature DC
precursors within the PB.
DC numbers are reported to be normal in op/op mice, and pre-
vious studies have noted GM-CSF to be the primary cytokine de-
termining DC development rather than CSF-1 (19, 20). In elegant
studies of macrophage and DC differentiation in vitro, IL-6 from
stromal cells has been shown to enhance CSF-1R expression on
monocytes and promote CSF-1-CSF-1R internalization. This re-
sults in the subsequent differentiation of monocytes to macro-
phages (21). In contrast, TNF- blocks CSF-1R expression and
internalization, leading to DC differentiation (22). These data sug-
gest that the absence of the CSF-1R expression would preferen-
tially block macrophage differentiation, consistent with the pheno-
type of the CSF-1 (op/op) and CSF-1R-deficient mice (23).
Because previous studies used poorly quantitative immunohisto-
logical techniques and predate the description of DC subsets, we
revisited the influence of CSF-1 on DC development in these mice
using a quantitative approach encompassing the wider understand-
ing of DC subset heterogeneity as published recently (24). These
data confirm that the absence of CSF-1 results in a 50–70% re-
duction in DC numbers, supporting the view that the low levels of
CSF-1R on DC are, indeed, functional. CSF-1 is also required for
optimal production of osteoclasts, hence, the osteopetrotic pheno-
type of the op/op mice. However, the op/op mice recover relatively
normal osteoclastogenesis with age, which is attributed to the abil-
ity of vascular endothelial growth factor-A and/or flt3 ligand, to
provide partial compensation (25, 26). Both these ligands act
through type III tyrosine kinase receptors closely related to c-fms.
Given the biology of flt3 ligand as a DC promoter, it is very likely
that it also provides partial compensation for the absence of CSF-1,
and of course, GM-CSF (which actually cross-modulates CSF-1
signaling (27)) may also contribute to DC homeostasis in the ab-
sence of CSF-1.
The majority of splenic CD11chigh DC is myeloid in origin
based on repopulation experiments and the relative frequency of
myeloid vs lymphoid precursors in vivo (2). In normal mice these
myeloid DC can be further divided into CD4, CD8, and
CD4CD8 subsets (6), and while the relative generation of these
subsets is not dependent of CSF-1 signaling, the optimal genera-
tion of CD11chigh myeloid DC in total does require CSF-1 (Table
I). Although we were unable to document a functional defect in the
ability of myeloid DC to stimulate allogeneic T cell responses, this
does not exclude more subtle defects, and therefore, we are cur-
rently studying the functional characteristics of DC from op/op
mice in detail. DC have been proposed as a separate lineage to
monocytes and macrophages based on the absence of CSF-1R on
PB and bone marrow-derived DC (28, 29). However, more re-
cently the CSF-1R was reported to be expressed on monocytes
before their differentiation to DC and the down-regulation of
CSF-1R by TNF- appears to be a critical component in driving
DC (as opposed to macrophage) development (22). Our data con-
firm and highlight the differential expression of CSF-1R on mac-
rophages and DC, and we propose that the differentiation of each
lineage is at least in part determined at the cellular level by c-fms
expression. Furthermore, the expression of c-fms by both myeloid
and plasmacytoid DC and their dependence on CSF-1 as seen by
the current studies in op/op mice also favors a common lineage for
these two DC subsets. Recent studies confirming the ability of
plasmacytoid DC to differentiate into myeloid DC following stim-
ulation by dsRNA and type I IFNs further supports this concept of
plasticity within DC subset lineages and their differentiation (30).
Thus, although both common myeloid and lymphoid progenitors
can give rise to both plasmacytoid and myeloid DC in vivo, these
subsets can no longer be unambiguously defined on arbitrary as-
sumptions of lineage (reviewed in Ref. 31). Our data provides
further support of this concept, suggesting that the majority of
tissue DC are of myeloid origin during steady state and that a close
relationship between DC and macrophage biology exists in vivo.
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